Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines

Hybridoma

Volumn 18, Issue 1, 1999, Pages 63-68

  Flieger, Dimitri ^a   Spengler, Ulrich ^a   Beier, Imke ^a   Kleinschmidt, Rolf ^a   Hoff, Anja ^a   Varvenne, Michael ^a   Sauerbruch, Tilman ^a   Schmidt Wolf, Ingo ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; EDRECOLOMAB; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CELL SELECTION; COLORECTAL TUMOR; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033001034     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1999.18.63     Document Type: Conference Paper

References (25)

1. Riethmuller G, Schneider Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, et al.: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 1994;343:1177-1183.
2. Maloney DG, Grillo Lopez AJ, Bodkin DJ, White CA, Liles TM, Royston I, Varns C, Rosenberg J, and Levy R: EDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodkin's lymphoma. J Clin Oncol 1997;15:3266-3274.
3. Herberman RB, Ortaldo JR, Mantovani A, Hobbs DS, Kung HF, and Pestka S: Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol 1982;67:160-167.
4. Munn DH, and Cheung NK: Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma. Cancer Res 1987;47:6600-6605.
5. Munn DH, and Cheung NK: Interleukin-2 enhancement of monoclonal antibody-mediated cellular ctotoxicity against human melanoma. Cancer Res 1987;47:6600-6605.
6. Ralph P, Nakoinz I, and Rennick D: Role of interleukin 2, interleukin 4, and alpha, beta, and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity. J Exp Med 1988;167:712-717.
7. Giacomini P, Tecce R, Gambari R, Sacchi A, Fisher PB, and Natali PG: Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism. J Immunol 1988;140:3073-3081.
8. Flieger D, Gruber R, Schlimok G, Reiter C, Pantel K, and Riethmuller G: A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells. J Immunol Methods 1995;180:1-13.
9. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968;97(Suppl.):77-89.
10. Herlyn M, Steplewski Z, Herlyn D, and Koprowski H: Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 1979;76:1438-1452.
11. Steplewski Z, Lubeck MD, Scholz D, Loibner H, McDonald Smith J, and Koprowski H: Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide. In Vivo 1991;5:79-83.
12. Bungard S, Flieger D, Schweitzer S, Sauerbruch T, and Spengler U: The combination of interleukin-2 and interferon-α effectively augments the antibody dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29. Cancer Immunol Immunother 1998;46:213-220.
13. Akiyama Y, Lubeck MD, Steplewski Z, and Koprowski H: Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. Cancer Res 1984;44:5127-5131.
14. Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, and Reisfeld R: Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol 1987;138:3566-3572.
15. Mufson RA, Aghajanian J, Wong G, Woodhouse C, and Morgan AC: Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol 1989;119:182-192.
16. Munn DH, and Cheung NK: Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. J Exp Med 1989;170:511-526.
17. Ragnhammar P, Frodin JE, Trotta PP, and Mellstedt H: Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunol Immunother 1994;39:254-262.
18. Liesveld JL, Frediani KE, Winslow JM, Duerst RE, and Abboud CN: Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity. J Cell Biochem 1991;45:381-390.
19. Masucci G, Wersall P, Ragnhammar P, and Mellstedt H: Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity. Cancer Immunol Immunother 1989;29:288-292.
20. Masucci G, Wersall P, Nielsen J, Nielsen HK, Wigzell H, and Mellstedt H: Lymphokine activated killer (LAK) cells in antibody dependent cellular cytotoxicity (ADCC) using MAb 17-1A: A combination of potential usefulness in tumor therapy. Hybridoma 1989;8:507-516.
21. Vuist WM, Visseren MJ, Otsen M, Bos K, Vyth Dreese FA, Figdor CG, Melief CJ, and Hekman A: Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon alpha. Cancer Immunol Immunother 1993;36:163-170.
22. Eisenthal A, and Rosenberg SA: The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha. J Immunol 1989;142:2307-2313.
23. Eisenthal A, and McIntosh JK: Effect of recombinant human tumor necrosis factor alpha on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules. Cancer Immunol Immunother 1990;31:243-249.
24. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, and Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
25. McKnight AJ, Zimmer GJ, Fogelman I, Wolf SF, and Abbas AK: Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol 1994;152:2172-2179.